Home Serum neuron-specific enolase – reference interval in Danish children and the impact of preanalytical factors
Article
Licensed
Unlicensed Requires Authentication

Serum neuron-specific enolase – reference interval in Danish children and the impact of preanalytical factors

  • Jacob Rudjord Therkildsen ORCID logo EMAIL logo , Cindy Søndersø Knudsen and Tina Parkner
Published/Copyright: October 3, 2025
Become an author with De Gruyter Brill

Abstract

Objectives

Neuron-specific enolase (NSE) is a clinically relevant biomarker used in the assessment of neuronal damage and in the diagnosis and monitoring of certain cancers. Despite its diagnostic importance, paediatric-specific reference intervals (RIs) for NSE are currently lacking. This study aimed to establish paediatric RIs for NSE in serum and to evaluate the influence of preanalytical factors on NSE measurements.

Methods

Residual serum samples from routine allergy testing in 242 Danish children (aged 0.1–17.9 years) were analysed using the Roche Elecsys® NSE assay on a Cobas platform. Both traditional non-parametric, age-partitioned RIs and continuous RIs derived via quantile regression were established. In addition, we assessed the impact of preanalytical variables, including haemolysis, and evaluated a previously proposed correction method for haemolysed samples within this cohort.

Results

Both the non-parametric and continuous approaches yielded consistent RIs, showing an age-dependent decline in serum NSE concentrations irrespective of sex. The traditional age-partitioned RI (95th percentile, one-sided) indicated upper limits of 36.9 μg/L and 32.0 μg/L for the age groups 0–5 and 6–17 years of age, based on samples with haemolysis <10 mg/dL haemoglobin.

Conclusions

This study defines age-specific paediatric RIs for serum NSE, demonstrating a physiological decline with age and highlighting higher NSE levels in healthy children compared to adults. Furthermore, within a limited range, a previously proposed simple linear correction method was validated for adjusting NSE values in mildly haemolysed samples using the newly established RIs.


Corresponding author: Jacob Rudjord Therkildsen, MD, PhD, Department of Clinical Biochemistry, Aarhus University Hospital, Palle Juul Jensens Boulevard 99, 8200 Aarhus, Denmark, E-mail:

Acknowledgments

The authors would like to sincerely thank laboratory technician Katrine Bremer for organising the analysis of blood samples and conducting preanalytical experiments.

  1. Research ethics: Not applicable. According to Danish legislation, no approval from an Ethical Committee was required for the present study using anonymized biological material only.

  2. Informed consent: Not applicable.

  3. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  5. Conflict of interest: The authors state no conflict of interest.

  6. Research funding: This study was funded by the Department of Clinical Biochemistry, Aarhus University Hospital.

  7. Data availability: The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

1. Isgrò, MA, Bottoni, P, Scatena, R. Neuron-specific enolase as a biomarker: biochemical and clinical aspects. Adv Cancer Biomarkers: Biochem Clin Crit Revision 2015;867:125–43. https://doi.org/10.1007/978-94-017-7215-0_9.Search in Google Scholar PubMed

2. Moore, BW, McGregor, D. Chromatographic and electrophoretic fractionation of soluble proteins of brain and liver. J Biol Chem 1965;240:1647–53. https://doi.org/10.1016/s0021-9258(18)97483-1.Search in Google Scholar

3. Iwanaga, T, Takahashi, Y, Fujita, T. Immunohistochemistry of neuron-specific and glia-specific proteins. Arch Histol Cytol 1989;52:13–24. https://doi.org/10.1679/aohc.52.suppl_13.Search in Google Scholar PubMed

4. Marangos, PJ, Zis, AP, Clark, RL, Goodwin, FK. Neuronal, non-neuronal and hybrid forms of enolase in brain – structural, immunological and functional comparisons. Brain Res 1978;150:117–33. https://doi.org/10.1016/0006-8993(78)90657-1.Search in Google Scholar PubMed

5. Marangos, PJ, Zis, AP, Clark, RL, Goodwin, FK. Neuronal, non-neuronal and hybrid forms of enolase in brain: structural, immunological and functional comparisons. Brain Res 1978;150:117–33. https://doi.org/10.1016/0006-8993(78)90657-1.Search in Google Scholar

6. Watanabe, M, Nagamine, T, Sakimura, K, Takahashi, Y, Kondo, H. Developmental study of the gene expression for alpha and gamma subunits of enolase in the rat brain by in situ hybridization histochemistry. J Comp Neurol 1993;327:350–8. https://doi.org/10.1002/cne.903270304.Search in Google Scholar PubMed

7. Kato, K, Suzuki, F, Umeda, Y. Highly sensitive immunoassays for three forms of rat brain enolase. J Neurochem 1981;36:793–7. https://doi.org/10.1111/j.1471-4159.1981.tb01663.x.Search in Google Scholar PubMed

8. Marangos, PJ, Campbell, IC, Schmechel, DE, Murphy, DL, Goodwin, FK. Blood platelets contain a neuron-specific enolase subunit. J Neurochem 1980;34:1254–8. https://doi.org/10.1111/j.1471-4159.1980.tb09967.x.Search in Google Scholar PubMed

9. Ramont, L, Thoannes, H, Volondat, A, Chastang, F, Millet, MC, Maquart, FX. Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice. Clin Chem Lab Med 2005;43:1215–7. https://doi.org/10.1515/cclm.2005.210.Search in Google Scholar

10. Haimoto, H, Takahashi, Y, Koshikawa, T, Nagura, H, Kato, K. Immunohistochemical localization of gamma-enolase in normal human-tissues other than nervous and neuro-endocrine tissues. Lab Invest 1985;52:257–63.Search in Google Scholar

11. Mu, RZ, Liu, S, Liang, KG, Jiang, D, Huang, YJ. A meta-analysis of neuron-specific enolase levels in cerebrospinal fluid and serum in children with epilepsy. Front Mol Neurosci 2020;13:24. https://doi.org/10.3389/fnmol.2020.00024.Search in Google Scholar PubMed PubMed Central

12. Cheng, F, Yuan, Q, Yang, J, Wang, W, Liu, H. The prognostic value of serum neuron-specific enolase in traumatic brain injury: systematic review and meta-analysis. PLoS One 2014;9:e106680. https://doi.org/10.1371/journal.pone.0106680.Search in Google Scholar PubMed PubMed Central

13. Brea, D, Sobrino, T, Blanco, M, Cristobo, I, Rodríguez-González, R, Rodríguez-Yañez, M, et al.. Temporal profile and clinical significance of serum neuron-specific enolase and S100 in ischemic and hemorrhagic stroke. Clin Chem Lab Med 2009;47:1513–18. https://doi.org/10.1515/cclm.2009.337.Search in Google Scholar

14. Alatas, OD, Gurger, M, Atescelik, M, Yildiz, M, Demir, CF, Ekingen, E, et al.. Neuron-specific enolase, S100 calcium-binding protein B, and heat shock protein 70 levels in patients with intracranial hemorrhage. Medicine (Baltim) 2015;94:e2007. https://doi.org/10.1097/md.0000000000002007.Search in Google Scholar PubMed PubMed Central

15. Luo, H, Shen, KX, Sun, HY, Li, RQ, Wang, ZM, Xie, ZS. Correlation study between serum neuro-specific enolase and gastric and colorectal cancers. Medicine 2020;99. https://doi.org/10.1097/md.0000000000019796.Search in Google Scholar PubMed PubMed Central

16. Riley, RD, Heney, D, Jones, DR, Sutton, AJ, Lambert, PC, Abrams, KR, et al.. A systematic review of molecular and biological tumor markers in neuroblastoma. Clin Cancer Res 2004;10:4–12. https://doi.org/10.1158/1078-0432.ccr-1051-2.Search in Google Scholar PubMed

17. Quoix, E, Purohit, A, Faller-Beau, M, Moreau, L, Oster, JP, Pauli, G. Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapy. Lung Cancer 2000;30:127–34. https://doi.org/10.1016/s0169-5002(00)00131-8.Search in Google Scholar PubMed

18. Panchal, AR, Bartos, JA, Cabanas, JG, Donnino, MW, Drennan, IR, Hirsch, KG, et al.. Part 3: adult basic and advanced life support: 2020 American heart association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2020;142:S366–468. https://doi.org/10.1161/cir.0000000000000916.Search in Google Scholar PubMed

19. Nolan, JP, Sandroni, C, Bottiger, BW, Cariou, A, Cronberg, T, Friberg, H, et al.. European resuscitation council and european society of intensive care medicine guidelines 2021: post-Resuscitation care. Resuscitation 2021;161:220–69. https://doi.org/10.1016/j.resuscitation.2021.02.012.Search in Google Scholar PubMed

20. Planche, V, Brochet, C, Bakkouch, A, Bernard, M. [importance of hemolysis on neuron-specific enolase measurement]. Ann Biol Clin 2010;68:239–42. https://doi.org/10.1684/abc.2010.0422.Search in Google Scholar PubMed

21. Verfaillie, CJ, Delanghe, JR. Hemolysis correction factor in the measurement of serum neuron-specific enolase. Clin Chem Lab Med 2010;48:891–2. https://doi.org/10.1515/cclm.2010.159.Search in Google Scholar PubMed

22. Tolan, NV, Vidal-Folch, N, Algeciras-Schimnich, A, Singh, RJ, Grebe, SK. Individualized correction of neuron-specific enolase (NSE) measurement in hemolyzed serum samples. Clin Chim Acta 2013;424:216–21. https://doi.org/10.1016/j.cca.2013.06.009.Search in Google Scholar PubMed

23. Lauwers, M, Frikha, A, Fage, D, Duterme, C, De Vos, N, Cotton, F, et al.. Development and validation of a simple correction method for the measurement of neuron-specific enolase in hemolyzed serum samples. Scand J Clin Lab Invest 2022;82:12–17. https://doi.org/10.1080/00365513.2021.2009021.Search in Google Scholar PubMed

24. Nome, RV, Paus, E, Gehin, JE, Bolstad, N, Bjoro, T. Managing hemolysis in serum neuron-specific enolase measurements - an automated algorithm for routine practice. Scand J Clin Lab Invest 2024;84:225–9. https://doi.org/10.1080/00365513.2024.2359091.Search in Google Scholar PubMed

25. Vermeer, HJ, Thomassen, E, de Jonge, N. Automated processing of serum indices used for interference detection by the laboratory information system. Clin Chem 2005;51:244–7. https://doi.org/10.1373/clinchem.2004.036301.Search in Google Scholar PubMed

26. Andersen, MN, Mouritzen, CV, Gabrieli, E. Mechanisms of plasma hemoglobin clearance after acute hemolysis: studies in open-heart surgical patients. Ann Surg 1966;163:529–36. https://doi.org/10.1097/00000658-196604000-00004.Search in Google Scholar PubMed PubMed Central

27. Johnsson, P, Blomquist, S, Luhrs, C, Malmkvist, G, Alling, C, Solem, JO, et al.. Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation. Ann Thorac Surg 2000;69:750–4. https://doi.org/10.1016/s0003-4975(99)01393-4.Search in Google Scholar PubMed

28. Kintzel, K, Sonntag, J, Strauss, E, Obladen, M. Neuron-specific enolase: reference values in cord blood. Clin Chem Lab Med 1998;36:245–7. https://doi.org/10.1515/CCLM.1998.042.Search in Google Scholar PubMed

29. Georgantzi, K, Skoldenberg, EG, Stridsberg, M, Kogner, P, Jakobson, A, Janson, ET, et al.. Chromogranin A and neuron-specific enolase in neuroblastoma: correlation to stage and prognostic factors. Pediatr Hematol Oncol 2018;35:156–65. https://doi.org/10.1080/08880018.2018.1464087.Search in Google Scholar PubMed

30. CLSI. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline. In: Wayne, PA, editor. CLSI document EP28-A3c, 3rd ed. Clinical and Laboratory Standards Institute; 2008.Search in Google Scholar

31. The EFLM biological variation database. https://biologicalvariation.eu/[Accesed: May 1, 2025]Search in Google Scholar

32. Holmes, DT, van der Gugten, JG, Jung, B, McCudden, CR. Continuous reference intervals for pediatric testosterone, sex hormone binding globulin and free testosterone using quantile regression. J Mass Spectrom Adv Clin Lab 2021;22:64–70. https://doi.org/10.1016/j.jmsacl.2021.10.005.Search in Google Scholar PubMed PubMed Central

33. Lahti, A, Petersen, PH, Boyd, JC, Rustad, P, Laake, P, Solberg, HE. Partitioning of nongaussian-distributed biochemical reference data into subgroups. Clin Chem 2004;50:891–900. https://doi.org/10.1373/clinchem.2003.027953.Search in Google Scholar PubMed

34. Schmechel, DE, Brightman, MW, Marangos, PJ. Neurons switch from non-neuronal enolase to neuron-specific enolase during differentiation. Brain Res 1980;190:195–214. https://doi.org/10.1016/0006-8993(80)91169-5.Search in Google Scholar PubMed

35. Abbasoglu, A, Sarialioglu, F, Yazici, N, Bayraktar, N, Haberal, A, Erbay, A. Serum neuron-specific enolase levels in preterm and term newborns and in infants 1-3 months of age. Pediatr Neonatol 2015;56:114–9. https://doi.org/10.1016/j.pedneo.2014.07.005.Search in Google Scholar PubMed

36. Tian, G, Wu, Y, Jin, X, Zeng, Z, Gu, X, Li, T, et al.. The incidence rate and influence factors of hemolysis, lipemia, icterus in fasting serum biochemistry specimens. PLoS One 2022;17:e0262748. https://doi.org/10.1371/journal.pone.0262748.Search in Google Scholar PubMed PubMed Central

37. Zeltzer, PM, Marangos, PJ, Evans, AE, Schneider, SL. Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course. Cancer 1986;57:1230–4. https://doi.org/10.1002/1097-0142(19860315)57:6<1230::aid-cncr2820570628>3.0.co;2-#.10.1002/1097-0142(19860315)57:6<1230::AID-CNCR2820570628>3.0.CO;2-#Search in Google Scholar

38. Tsuchida, Y, Honna, T, Iwanaka, T, Saeki, M, Taguchi, N, Kaneko, T, et al.. Serial determination of serum neuron-specific enolase in patients with neuroblastoma and other pediatric tumors. J Pediatr Surg 1987;22:419–24. https://doi.org/10.1016/s0022-3468(87)80261-0.Search in Google Scholar

39. Berthold, F, Engelhardt-Fahrner, U, Schneider, A, Schumacher, R, Zieschang, J. Age dependence and prognostic impact of neuron specific enolase (NSE) in children with neuroblastoma. Vivo 1991;5:245–7.Search in Google Scholar

40. Zhao, H, Zhu, D, Zhang, M, Wang, T, Han, N, Ge, T, et al.. Establishing neuron-specific enolase reference intervals: a comparative analysis of partitioned Approach- and gender-based continuous Age- and season-related models. Diagnostics 2024;14. https://doi.org/10.3390/diagnostics14192226.Search in Google Scholar

41. Tybirk, L, Hviid, CVB, Knudsen, CS, Parkner, T. Serum GFAP - pediatric reference interval in a cohort of Danish children. Clin Chem Lab Med 2023;61:2041–5. https://doi.org/10.1515/cclm-2023-0280.Search in Google Scholar

42. Rodriguez-Rodriguez, A, Egea-Guerrero, JJ, Vilches-Arenas, A, Guerrero, JM, Murillo-Cabezas, F. Effect of freezing-thawing process on neuron specific enolase concentration in severe traumatic brain injury sera samples. Clin Chem Lab Med 2014;52:e65–7. https://doi.org/10.1515/cclm-2013-0713.Search in Google Scholar

43. Rundgren, M, Cronberg, T, Friberg, H, Isaksson, A. Serum neuron specific enolase - impact of storage and measuring method. BMC Res Notes 2014;7:726. https://doi.org/10.1186/1756-0500-7-726.Search in Google Scholar

44. Wang, Q, Wang, GR, Lu, XL, Guo, XL, Du, Q, Lin, F, et al.. A correction formula for neuron-specific enolase measurement in hemolyzed neonatal serum samples. Biomed Rep 2018;8:491–6. https://doi.org/10.3892/br.2018.1081.Search in Google Scholar


Supplementary Material

This article contains supplementary material (https://doi.org/10.1515/cclm-2025-0582).


Received: 2025-05-13
Accepted: 2025-09-23
Published Online: 2025-10-03

© 2025 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 2.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2025-0582/html
Scroll to top button